Search Results 1121-1130 of 17731 for Blind spot
The purpose of this pilot study is to develop and test a technology-enhanced transitional palliative care (TPC) intervention for patients and caregivers living ...
The framework was highly successful, reaching thousands of people in the Rochester area. It was later adopted by three other groups conducting community ...
This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and ...
Incidence not known. Persistent non-healing sore; pink growth; reddish patch or irritated area; shiny bump; white, yellow or waxy scar-like area. Some side ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Rodolfo Savica, M.D., Ph.D., studies biomarkers and risk factors to improve diagnosis and treatment of early-onset Parkinson's and related disorders.
The purpose of this study is to understand the aqueous humor dynamics changes that occur with glaucoma therapies and provocative tests. Participation ...
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy.
About this study. The purpose of this study is to quantify potential decreases in visual acuity experienced by patients who experience mid-day fogging ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!